Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have higher 5alpha-reductase activity, affecting steroid levels.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

Ketoconazole reduced hair growth and improved acne in women, but caused side effects needing careful monitoring.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

Men with Kennedy disease have less chance of hair loss.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

Finasteride significantly reduces hair growth in women with idiopathic hirsutism.

Scalp hair grows at 0.37 mm/day, forearm hair at 0.18 mm/day, and thigh hair at 0.30 mm/day, with no significant differences found in people with certain hair conditions.

Acne severity in women may not be linked to increased male hormone indicators like excess body hair, menstrual irregularities, or hair loss.

Laser hair removal is safe and effective for fair-skinned people with dark hair, and using eflornithine with laser treatments can improve results.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Obese women with PCOS have lower vitamin D levels.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Chromium picolinate was better tolerated than metformin for PCOS with fewer side effects.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Children's hair grows in different types from before birth through puberty, with growth rates and characteristics varying by age, sex, and race.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

Menopause affects hair and skin; more research needed for treatment.

Hair loss in women not always linked to increased oil production; other factors may be involved.

The long-pulsed alexandrite laser is effective for hair reduction, particularly for light-skinned individuals with dark hair, but caution is needed for darker skin.